本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Phathom Pharmaceuticals

14.55
+0.34002.39%
盤前14.13-0.4200-2.89%07:40 EST
成交量:67.14萬
成交額:966.41萬
市值:10.35億
市盈率:-3.83
高:14.64
開:14.20
低:14.12
收:14.21
52周最高:16.27
52周最低:2.21
股本:7,113.84萬
流通股本:5,195.01萬
量比:0.87
換手率:1.29%
股息:- -
股息率:- -
每股收益(TTM):-3.8010
每股收益(LYR):-5.2920
淨資產收益率:-3489.00%
總資產收益率:-42.54%
市淨率:-2.45
市盈率(LYR):-2.75

資料載入中...

2023/05/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/25

重要事件披露

Form 8-K - Current report
2023/05/23

重要事件披露

Form 8-K - Current report
2023/05/10

重要事件披露

8-K - Current report
2023/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/04/04

重要事件披露

8-K - Current report
2023/03/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/28

重要事件披露

8-K - Current report
2023/02/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

重要事件披露

8-K - Current report
2023/02/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/31

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2023/01/03

重要事件披露

8-K - Current report
2022/11/09

[修訂]季度報告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2022/11/09

重要事件披露

8-K - Current report